What level of efficacy is seen in adolescent patients vs the overall population of patients on ritlecitinib?
Featuring Glynis Ablon, MD |
Associate Clinical Professor
University of California, Los Angeles
Ablon Skin Institute & Research Center
Los Angeles, CA
Related CME
Related Media
Powered by Polaris TM